BIOGEN INC
424B3, 1999-02-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MPSI SYSTEMS INC, SC 13G/A, 1999-02-08
Next: BIOGEN INC, SC 13G/A, 1999-02-08



                                             

                                                Filed Pursuant to Rule 424(b)(3)

                                                      REGISTRATION NO. 333-42887


           PROSPECTUS SUPPLEMENT NO. 1 DATED FEBRUARY 5, 1999 TO THE
                      PROSPECTUS DATED FEBRUARY 2, 1999 OF
                                  BIOGEN, INC.


This Prospectus  Supplement No. 1 amends the information  contained in the table
under the caption  "Selling  Stockholders"  in the Prospectus  dated February 2,
1999 by deleting the information as to James L. Vincent in the body of the table
and footnote (2) thereto, and substituting therefor the following information:

<TABLE>
<CAPTION>

                     Number of                             Shares to be
                     Shares           Number of            Beneficially
                     Beneficially     Shares to            Owned After
Name                 Owned            be Offered           Offering
<S>                  <C>              <C>               <C>            <C>   
                                                        Number         Percent
James L. Vincent(1)  860,499(2)       634,300           226,199(3)       *

     ------------------------------------  
<FN>
(2)  Includes  (i)  6,800  shares  of  common  stock  acquired  by  the  selling
stockholder through the exercise of options granted under the Plan, (ii) 852,500
Shares of common  stock which the selling  stockholder  has the right to acquire
through  the  exercise  of  options  granted  under the  Plan,  all of which are
currently  exercisable  and (iii) an  estimated  1,199  shares  of common  stock
representing the selling  stockholder's  beneficial  interest in a Biogen 401(k)
plan. 
</FN>
</TABLE>

                     --------------------------------------

     This  Prospectus  Supplement  No. 1 forms a part of and  should  be read in
conjunction with the Prospectus dated February 2, 1999.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission